about
Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers.Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas.L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.Incidence of and risk factors for surgical site infections in women undergoing hysterectomy for endometrial carcinoma.Global metabolomic profiling of uterine leiomyomas.Preoperative Risk Stratification of Endometrial Carcinoma: L1CAM as a Biomarker.Prediction of Site-Specific Tumor Relapses in Patients With Stage I-II Endometrioid Endometrial Cancer.L1CAM expression associates with poor outcome in endometrioid, but not in clear cell ovarian carcinoma.Prediction of lymphatic dissemination in endometrioid endometrial cancer: Comparison of three risk-stratification models in a single-institution cohort.Molecular changes preceding endometrial and ovarian cancer: a study of consecutive endometrial specimens from Lynch syndrome surveillance.[Is endometriosis a premalignant condition to ovarian carcinoma?].Genetic predisposition to uterine leiomyoma is determined by loci for genitourinary development and genome stabilityConverging endometrial and ovarian tumorigenesis in Lynch syndrome: Shared origin of synchronous carcinomasEsophageal small cell carcinomaRisk-stratification of endometrial carcinomas revisited: a combined preoperative and intraoperative scoring system for a reliable prediction of an advanced diseaseClinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in endometrioid endometrial carcinoma
P50
Q31038292-1DF8A48B-7293-4CFD-AB53-352EA957383BQ33682500-1DF7F2E4-D16D-4274-9C8B-BAABEB766362Q39371331-0068D229-F1AF-4123-AB84-7BBED9EE7C95Q40218191-919B5371-8469-4170-AA4D-E4C438C87C06Q47599682-A7E47E27-4DA8-4D70-854A-2143EAF6A088Q47636523-38EF0C49-6DF7-4771-BB6E-C54B6FEC391DQ50652738-A95C46AA-0A07-4B27-A8E5-9A01C79925CBQ50938897-8A78197D-23C7-4A6A-86E5-C83EA5E0B6B0Q50961280-5AAC419A-AB91-4410-AEA9-1C50E5C0A155Q52339892-849B6B89-0CEA-4BF0-97A1-A393ED296900Q53253188-3E072FEA-1EC5-466F-9B84-4E35CA3575A1Q58721388-82FB62E3-8E23-465B-906F-F4C928C4342FQ59272586-BF993B34-F5D8-44AC-BA76-3886E1995567Q83765427-A6958846-DC87-479E-AD5D-036A870723CFQ86642952-B043A465-0316-4DB3-99C5-F606851DAEB6Q89723158-393CCB68-1170-47EC-9F41-C1ACB851F5AC
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Annukka Pasanen
@ast
Annukka Pasanen
@en
Annukka Pasanen
@es
Annukka Pasanen
@nl
Annukka Pasanen
@sl
type
label
Annukka Pasanen
@ast
Annukka Pasanen
@en
Annukka Pasanen
@es
Annukka Pasanen
@nl
Annukka Pasanen
@sl
prefLabel
Annukka Pasanen
@ast
Annukka Pasanen
@en
Annukka Pasanen
@es
Annukka Pasanen
@nl
Annukka Pasanen
@sl
P106
P31
P496
0000-0002-0079-9807